2016-08-29 Real-World Data from Multiple Countries Continue to Reaffirm Positive Benefit-Risk Profile of Bayer’s Xarelto® in Everyday Clinical Practice
2016-08-22 New Real-World Evidence on Venous and Arterial Blood Clot Management including Bayer’s Xarelto® Accepted for Presentation at ESC Congress 2016
2016-08-19 Bayer and CRISPR Therapeutics joint venture, named Casebia Therapeutics, establishes operations in Cambridge, MA
